Skip to main content
. 2021 Apr 13;10(4):599. doi: 10.3390/antiox10040599
b.wt. Body weight
DPPH 1:1-diphenyl-1-picryl-hydrazyl
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
AIA Antigen-induced arthritis
CCK-8 Cell counting kit-8
JNK c-Jun NH2-terminal kinase
CIA Collagen-induced arthritis
Cs Conventional synthetic
CRP C-Reactive protein
COX Cyclooxygenase
DPPI Dipeptidyl peptidase I
DMARDs Disease-modifying antirheumatic drugs
ESR Erythrocyte Sedimentation Rate
ERK Extracellular signal-regulated kinase
FRAP Ferric reducing antioxidant power
FLS Fibroblast-like synoviocytes
Foxp3 Forkhead box P3
FCA Freund’s complete adjuvant
GMC-SF Granulocyte-macrophage colony-stimulating factor
Hb Hemoglobin
iNOS Inducible NO synthetase
IRF-4 Interferon Regulatory Factor 4
IL Interleukin
LPS Lipopolysaccharide
MMP Matrix metalloproteinases
MTX Methotrexate
MARK Mitogen-activated protein kinase
NSAIDs Nonsteroidal anti-inflammatory drugs
NO Nitric oxide
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
Nrf2 Nuclear factor (erythroid-derived 2)-like 2
PBMCs Peripheral blood mononuclear cytokines
PGE2 Prostaglandin E2
RORγt RAR-related orphan receptor gamma
ROS Reactive oxygen species
RANKL Receptor activator of nuclear factor kappa-B ligand
Treg Regulatory T cells
RA Rheumatoid arthritis
RF Rheumatoid factor
shRNA Short hairpin RNA
STAT3 Signal transducer and activator of transcription 3
SEM Standard error of the mean
SF Synovial fluid
Th T helper
TUNEL assay Terminal deoxynucleotidyl transferase dUTP nick end labeling assay
TCM Traditional Chinese medicine
TGF-β Transforming growth factor-β
TEAC Trolox equivalent antioxidant capacity
TNF Tumor necrosis factor
HHS Vulnerability Disclosure